Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Vistagen Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- −2 vs. Q3 2025
- Shares held
- 13.8M
- −9.57M (−41.0%) vs. Q3 2025
- Total value
- $8.84M
- −$72.8M (−89.2%) vs. Q3 2025
- New holders
- 14
- 18 more added
- Sold out
- 16
- 15 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $2.54M |
| Q1 2026 | 56 | $8.12M |
| Q4 2025 | 55 | $8.84M |
| Q3 2025 | 58 | $81.8M |
| Q2 2025 | 51 | $30.3M |
| Q1 2025 | 48 | $39.0M |
| Q4 2024 | 54 | $44.9M |
| Q3 2024 | 47 | $45.3M |
| Q2 2024 | 43 | $56.3M |
| Q1 2024 | 42 | $90.8M |
| Q4 2023 | 46 | $90.0M |
| Q3 2023 | 34 | $15.7M |
| Q2 2023 | 33 | $1.82M |
| Q1 2023 | 83 | $4.79M |
| Q4 2022 | 86 | $4.15M |
| Q3 2022 | 93 | $9.13M |
| Q2 2022 | 112 | $122.1M |
| Q1 2022 | 116 | $167.8M |
| Q4 2021 | 106 | $269.2M |
| Q3 2021 | 105 | $360.2M |
| Q2 2021 | 101 | $389.0M |
| Q1 2021 | 74 | $225.2M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 582 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 13 | $9 | 0.00% | −43−76.8% | Reduced |
| JPMorgan Chase & Co | 16 | $11 | 0.00% | −271,809−100.0% | Reduced |
| Fairman Group, LLC | 29 | $19 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 114 | $75 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 288 | $191 | 0.00% | −2−0.7% | Reduced |
| MAI Capital Management | 526 | $349 | 0.00% | 00.0% | Unchanged |
| Performa Ltd (US), LLC | 1,000 | $662 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,145 | $2.08K | 0.00% | −31,512−90.9% | Reduced |
| Advisor Group Holdings, Inc. | 5,269 | $3.48K | 0.00% | +1,176+28.7% | Added |
| Tower Research Capital LLC (TRC) | 8,564 | $5.67K | 0.00% | +8,564 | New |
| DRW Securities, LLC | 10,000 | $6.62K | 0.00% | +10,000 | New |
| Morgan Stanley | 12,658 | $8.38K | 0.00% | −14,876−54.0% | Reduced |
| StoneX Group Inc. | 13,349 | $8.84K | 0.00% | +13,349 | New |
| Caption Management, LLC | 16,770 | $11.1K | 0.00% | +16,770 | New |
| Truvestments Capital LLC | 16,992 | $11.2K | 0.00% | +8,337+96.3% | Added |
| Marshall Wace, LLP | 19,973 | $13.2K | 0.00% | +19,973 | New |
| Lighthouse Investment Partners, LLC | 20,580 | $13.6K | 0.00% | +20,580 | New |
| HighTower Advisors, LLC | 20,628 | $13.7K | 0.00% | −200−1.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 21,736 | $14.4K | 0.00% | +10,853+99.7% | Added |
| Charles Schwab Investment Management Inc | 23,302 | $15.4K | 0.00% | 00.0% | Unchanged |
| Kestra Advisory Services, LLC | 26,033 | $17.2K | 0.00% | +6,000+30.0% | Added |
| Persistent Asset Partners Ltd | 26,612 | $17.6K | 0.01% | −48,707−64.7% | Reduced |
| Engineers Gate Manager LP | 30,490 | $20.2K | 0.00% | +30,490 | New |
| HRT Financial LP | 37,585 | $24.0K | 0.00% | +37,585 | New |
| Virtu Financial LLC | 37,739 | $25.0K | 0.00% | +37,739 | New |
| American Century Companies Inc | 48,770 | $32.3K | 0.00% | +7,698+18.7% | Added |
| UBS Group AG | 51,993 | $34.4K | 0.00% | +26,326+102.6% | Added |
| Occudo Quantitative Strategies LP | 59,038 | $39.1K | 0.00% | +16,334+38.2% | Added |
| Qube Research & Technologies Ltd | 60,139 | $39.8K | 0.00% | +60,139 | New |
| Seven Fleet Capital Management LP | 62,701 | $41.5K | 0.03% | +62,701 | New |
| Northern Trust Corp | 72,655 | $48.1K | 0.00% | +24,562+51.1% | Added |
| Tudor Investment Corp Et Al | 76,172 | $50.4K | 0.00% | +76,172 | New |
| Diadema Partners LP | 100,000 | $66.2K | 0.04% | −249,789−71.4% | Reduced |
| Omers Administration Corp | 103,400 | $68.4K | 0.00% | +103,400 | New |
| Group One Trading, L.P. | 106,137 | $70.3K | 0.00% | +77,209+266.9% | Added |
| State Street Corp | 121,114 | $80.2K | 0.00% | +24,256+25.0% | Added |
| Boothbay Fund Management, LLC | 134,571 | $89.1K | 0.00% | −62,453−31.7% | Reduced |
| Two Sigma Advisers, LP | 137,732 | $91.2K | 0.00% | −19,300−12.3% | Reduced |
| Dimensional Fund Advisors LP | 151,874 | $100.6K | 0.00% | +83,857+123.3% | Added |
| Renaissance Technologies LLC | 160,791 | $106.4K | 0.00% | −261,221−61.9% | Reduced |
| Two Sigma Investments, LP | 195,570 | $129.4K | 0.00% | −93,839−32.4% | Reduced |
| Millennium Management LLC | 197,045 | $130.4K | 0.00% | +176,369+853.0% | Added |
| StemPoint Capital LP | 616,749 | $142.1K | 0.02% | −1,871,936−75.2% | Reduced |
| AdvisorShares Investments LLC | 250,188 | $165.6K | 0.03% | +43,190+20.9% | Added |
| Susquehanna International Group, LLP | 334,786 | $221.6K | 0.00% | +249,192+291.1% | Added |
| Luminus Management LLC | 350,000 | $231.7K | 0.21% | +350,000 | New |
| Geode Capital Management, LLC | 352,836 | $233.6K | 0.00% | +54,556+18.3% | Added |
| BlackRock, Inc. | 422,759 | $279.8K | 0.00% | −369−0.1% | Reduced |
| Ikarian Capital, LLC | 519,077 | $343.6K | 0.04% | −101,792−16.4% | Reduced |
| Jane Street Group, LLC | 527,127 | $348.9K | 0.00% | +224,444+74.2% | Added |
| ADAR1 Capital Management, LLC | 623,575 | $412.7K | 0.03% | +510,513+451.5% | Added |
| Vanguard Group Inc | 1,824,738 | $1.21M | 0.00% | +137,003+8.1% | Added |
| TCG Crossover Management, LLC | 2,676,580 | $1.77M | 0.06% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,060,000 | $2.03M | 0.04% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −4,165,767−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −1,978,492−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −1,575,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Almitas Capital LLC | 0 | $0 | 0.00% | −261,399−100.0% | Sold out |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −122,062−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −69,712−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −67,770−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −60,152−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −31,486−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −15,752−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −12,573−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −3,453−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |